Management of third stage of labour

Intraumbalical vein versus intravenous oxytocin injection for mangment the third stage of labor: A Randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201707002372422

Enrollment

400

Registered

2017-06-23

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth managment of tird stage of labour

Interventions

intraumblical vein oxytocin injection for management of 3rd stage of labour

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women for normal vaginal delivarywith low risk of post partum hemorrhage, Gestational age; 37 to 41 weeks Parity; PG,,P1-P4 singleton pregnancy Presentation; alive fetus with cephalic Birth weight;2500 to 3500gr placenta; anterior, posterior, fundal

Exclusion criteria

Exclusion criteria: All women with high risk for post partum hemorrhage ;-All maternal medical diseases as Hypertensive disorders,diabetes, cardiac disorders,anemia -Placentaprevia -Placenta abruption -Historyofbleeding after delivery in previous pregnancy -history of curettage or cesarean delivery or uterinescar,

Design outcomes

Primary

Measure	Time frame
the amount of blood loss in the third and fourth stages of labor.2-duration of the third stage of labor	—

Secondary

Measure	Time frame
1-the incidences of postpartum hemorrhage(500 mL or greater), severe postpartum hemorrhage (1,000 mL or greater), 2- percentage of retained placenta	—

Countries

Egypt

Contacts

Public ContactAhmed Abdel Aleem

lecturer of obestetiic and gynacology faculty of medicine Assuit university

aboaliabdelaleem@gmail.com01001085865

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026